Friday, November 30, 2012

Supreme Court to Review Patentability of Human Genes

Today the Supreme Court agreed to review the Myriad gene patenting case, Association for Molecular Pathology v. Myriad Genetics. The case involved the patentability of genes directed to detection of breast cancer (BRCA genes) and methods for using them. The review is limited to question 1, which asks whether human genes are patentable.  I previously wrote about the case here and here; SCOTUSblog's case page is here.

No comments:

Post a Comment